Related Experiment Video

Updated: Oct 9, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.5K

KLF5, a Novel Therapeutic Target in Squamous Cell Carcinoma

Shuo Yang1, Ting Feng1, Hong Li1

  • 1Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital of Sichuan University, Chengdu, China.

DNA and Cell Biology
|December 21, 2021
PubMed

Insights

Krüppel-like factor 5 (KLF5) promotes squamous cell carcinoma (SCC) growth and progression. Targeting KLF5 may offer new diagnostic and therapeutic strategies for SCCs, a common and deadly cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Squamous cell carcinomas (SCCs) are common ectodermal cancers causing over 300,000 annual deaths.
  • Krüppel-like transcription factors are crucial in cancer development.
  • The Krüppel-like factor 5 (KLF5) gene is implicated in promoting cancer cell proliferation and tumor formation.

Purpose of the Study:

  • To review the role of KLF5 in various SCCs.
  • To elucidate the mechanisms of KLF5-mediated transcriptional regulation in SCC pathogenesis and progression.

Main Methods:

  • Literature review of studies on KLF5 in SCC.
  • Analysis of KLF5's transcriptional regulatory functions.
  • Examination of KLF5's impact on cell proliferation and differentiation.

Main Results:

  • KLF5 plays a significant role in the pathogenesis and progression of different types of SCCs.
  • KLF5 transcriptionally regulates target genes involved in cancer development.
  • KLF5 influences cancer cell proliferation and differentiation processes.

Conclusions:

  • KLF5 is a key factor in SCC development and progression.
  • KLF5's functions in cell proliferation and differentiation suggest its potential as a therapeutic target.
  • KLF5 may serve as a novel diagnostic biomarker for SCCs.
Keywords:
KLF5cancer therapeuticssquamous cell carcinomatranscription factor

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K